RWM
AGIO icon

Rialto Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

Rialto Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38 Hold
1
– – ﹤0.01% 1923
2026
Q1 		$34 Sell
1
-1
-50% -$28 ﹤0.01% 1711
2025
Q4 		$55 Hold
2
– – ﹤0.01% 1674
2025
Q3 		$81 Hold
2
– – ﹤0.01% 1642
2025
Q2 		$67 Buy
+2
New +$61 ﹤0.01% 1591

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Rialto Wealth Management's AGIO Position: Q2 2026 in Review

Rialto Wealth Management held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 1 share worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Rialto Wealth Management first reported a position in AGIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $81 in Q3 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Rialto Wealth Management held 1 share of Agios Pharmaceuticals worth $38 as of Q2 2026.
  • Rialto Wealth Management left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1923 holding.
  • Rialto Wealth Management first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Rialto Wealth Management's Agios Pharmaceuticals position peaked at $81 in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.